$0.22 EPS Expected for HCA Healthcare Inc (NYSE:HCA) This Quarter

Equities analysts predict that HCA Healthcare Inc (NYSE:HCA) will report earnings of $0.22 per share for the current fiscal quarter, according to Zacks Investment Research. Nine analysts have made estimates for HCA Healthcare’s earnings, with estimates ranging from ($0.24) to $0.57. HCA Healthcare reported earnings per share of $2.23 during the same quarter last year, which would suggest a negative year-over-year growth rate of 90.1%. The company is scheduled to issue its next earnings report on Tuesday, November 3rd.

According to Zacks, analysts expect that HCA Healthcare will report full year earnings of $11.98 per share for the current fiscal year, with EPS estimates ranging from $10.96 to $13.99. For the next fiscal year, analysts forecast that the business will post earnings of $11.47 per share, with EPS estimates ranging from $9.20 to $12.70. Zacks’ EPS calculations are an average based on a survey of sell-side analysts that follow HCA Healthcare.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Wednesday, July 22nd. The company reported $3.23 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.94) by $4.17. The business had revenue of $11.07 billion during the quarter, compared to analysts’ expectations of $10.44 billion. HCA Healthcare had a negative return on equity of 589.47% and a net margin of 6.67%. The firm’s quarterly revenue was down 12.2% compared to the same quarter last year. During the same quarter in the previous year, the business earned $2.21 earnings per share.

A number of analysts have commented on the company. Deutsche Bank lifted their target price on HCA Healthcare from $132.00 to $150.00 in a report on Thursday, July 23rd. SunTrust Banks lifted their target price on HCA Healthcare from $130.00 to $150.00 and gave the stock a “buy” rating in a report on Thursday, July 23rd. Mizuho lifted their target price on HCA Healthcare from $136.00 to $145.00 and gave the stock a “buy” rating in a report on Thursday, July 23rd. JPMorgan Chase & Co. lowered HCA Healthcare from an “overweight” rating to a “neutral” rating and reduced their target price for the stock from $161.00 to $143.00 in a report on Monday, September 21st. Finally, BMO Capital Markets lowered HCA Healthcare from an “outperform” rating to a “market perform” rating and reduced their target price for the stock from $121.00 to $100.00 in a report on Monday, July 13th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and sixteen have assigned a buy rating to the company. The stock presently has an average rating of “Buy” and an average price target of $148.89.

Shares of HCA Healthcare stock traded down $0.12 on Friday, reaching $124.56. The company’s stock had a trading volume of 1,845,666 shares, compared to its average volume of 2,469,063. The company has a market capitalization of $42.11 billion, a price-to-earnings ratio of 12.84, a P/E/G ratio of 1.22 and a beta of 1.40. The firm’s fifty day simple moving average is $131.85 and its two-hundred day simple moving average is $111.28. HCA Healthcare has a 52 week low of $58.38 and a 52 week high of $151.97. The company has a quick ratio of 0.95, a current ratio of 1.09 and a debt-to-equity ratio of 54.19.

In other news, insider A Bruce Moore, Jr. sold 15,000 shares of the business’s stock in a transaction dated Tuesday, August 11th. The stock was sold at an average price of $133.73, for a total value of $2,005,950.00. Following the transaction, the insider now directly owns 88,626 shares in the company, valued at $11,851,954.98. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP P. Martin Paslick sold 254 shares of the business’s stock in a transaction dated Thursday, August 6th. The shares were sold at an average price of $132.97, for a total value of $33,774.38. Following the completion of the transaction, the senior vice president now owns 5,442 shares in the company, valued at $723,622.74. The disclosure for this sale can be found here. Insiders sold 15,481 shares of company stock worth $2,070,363 over the last 90 days. Company insiders own 1.80% of the company’s stock.

Large investors have recently bought and sold shares of the stock. Kore Private Wealth LLC lifted its position in shares of HCA Healthcare by 164.7% in the second quarter. Kore Private Wealth LLC now owns 270 shares of the company’s stock worth $26,000 after buying an additional 168 shares in the last quarter. Smithfield Trust Co. lifted its position in shares of HCA Healthcare by 96.8% in the second quarter. Smithfield Trust Co. now owns 305 shares of the company’s stock worth $30,000 after buying an additional 150 shares in the last quarter. Mark Sheptoff Financial Planning LLC purchased a new stake in shares of HCA Healthcare in the second quarter worth about $34,000. Leelyn Smith LLC purchased a new stake in shares of HCA Healthcare in the second quarter worth about $40,000. Finally, TCTC Holdings LLC purchased a new stake in shares of HCA Healthcare in the second quarter worth about $49,000. Institutional investors own 68.28% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Featured Article: Relative Strength Index

Get a free copy of the Zacks research report on HCA Healthcare (HCA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.